Metraipolis › archive › dc_dfabb238ea1a

Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments — Europe PMC PMID:42121884

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42121884
DOI: 10.3390/cells15090783
License (as archived): solo-consultazione
Archived: 2026-10-08T00:47:42.829Z
SHA-256 of the archived text: dc6368709d54ae782794a51aa02fbcac6892503e2a253d2f47ac39e44eb487d8
Stable URL of this page: https://metraipolis.com/documento/dc_dfabb238ea1a

How to cite

Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments — Europe PMC PMID:42121884 — Europe PMC (en), https://europepmc.org/article/MED/42121884 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfabb238ea1a (Metraipolis archive dc_dfabb238ea1a, sha256 dc6368709d54ae782794a51aa02fbcac6892503e2a253d2f47ac39e44eb487d8)

BibTeX

@misc{dcdfabb238ea1a,
  title = {Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments — Europe PMC PMID:42121884},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42121884},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfabb238ea1a; sha256 dc6368709d54ae782794a51aa02fbcac6892503e2a253d2f47ac39e44eb487d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42121884. Agents can read the archived copy with the MCP tool read_document.